Viewing Study NCT06190093


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2025-12-27 @ 2:44 AM
Study NCT ID: NCT06190093
Status: COMPLETED
Last Update Posted: 2025-02-25
First Post: 2023-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)
Sponsor: Outlook Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-01-24
Start Date Type: ACTUAL
Primary Completion Date: 2024-11-07
Primary Completion Date Type: ACTUAL
Completion Date: 2024-12-05
Completion Date Type: ACTUAL
First Submit Date: 2023-12-19
First Submit QC Date: None
Study First Post Date: 2024-01-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-21
Last Update Post Date: 2025-02-25
Last Update Post Date Type: ACTUAL